Stock Events

Stock Events

UroGen Pharma (URGN) Q3 2024 Earnings

13AugConfirmed

Q3 2023

Q4 2023

Q2 2024

Q3 2024

-0.97

-0.87

-0.78

-0.68

Details

Expected EPS

-0.832

Actual EPS

-0.91

Surprise EPS

-0.08

Surprise Percent

+9.38%

Description

UroGen Pharma (URGN) has reported earnings of -0.91 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.